Gennex Laboratories Ltd Stock Analysis

BSE: 531739 | NSE: | Pharmaceuticals & Drugs | Small Cap

BSE Share Price 09-Jun-2023 17:11
7.01 0.14 (2.04%)

DeciZen - Make an Informed Decision on Gennex Lab

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity

1. Quality

2. Valuation


3. Price Trend

Gennex Lab Price Chart

P/E Ratio ( SA) :
Market Cap :
123 Cr.
52-wk low :
52-wk high :
Bole Toh?

1. Is Gennex Laboratories Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Gennex Laboratories Ltd is a below average quality company.

2. Is Gennex Laboratories Ltd undervalued or overvalued?

The key valuation ratios of Gennex Laboratories Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Gennex Laboratories Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Gennex Laboratories Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Gennex Lab:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Gennex Laboratories Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

ROCE % 2.2%1.2%3.3%9%9.9%3.9%7.6%5.5%10.4%8.4%-
Value Creation Index -0.8-0.9-0.8-0.4-0.3-0.7-0.5-0.6-0.3-0.4-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 29.93531.938.641.943.855.855.659.761.267
YoY Gr. Rt. %-17%-8.8%20.9%8.7%4.5%27.5%-0.3%7.3%2.6%-
YoY Gr. Rt. %--66.7%400%260%16.7%-71.4%183.3%-29.4%158.3%-9.7%-
BVPS (₹)
Adj Net Profit
Cash Flow from Ops. -
Debt/CF from Ops. -1.46.518.60.7-


CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 8.3%7.9%3.1%2.6%
Adj EPS 28.2%5.9%18.1%-9.7%
Share Price 25.2% 16.3% 20.7% 2.3%

Key Financial Parameters

Performance Ratio Colour Code Guide

Return on Equity %
Op. Profit Mgn %
Net Profit Mgn % 1.30.326.16.5242.96.865.9
Debt to Equity
Working Cap Days 1291471811601852031611842042130
Cash Conv. Cycle -3-13-126102153325410

Recent Performance Summary

Net Profit is growing at healthy rate in last 3 years 18.10%

Sales growth is good in last 4 quarters at 19.53%

Return on Equity has declined versus last 3 years average to 7.10%

Sales growth has been subdued in last 3 years 3.13%

Latest Financials - Gennex Laboratories Ltd.

Standalone Consolidated
TTM EPS (₹) 0.2 0.2
TTM Sales (₹ Cr.) 67.1 61.2
BVPS (₹.) 2.9 3.3
Reserves (₹ Cr.) 34 42
P/BV 2.36 2.06
PE 31.07 29.96
From the Market
52 Week Low / High (₹) 4.81 / 9.10
All Time Low / High (₹) 0.22 / 14.16
Market Cap (₹ Cr.) 123
Equity (₹ Cr.) 17.9
Face Value (₹) 1
Industry PE 38.1

Management X-Ray of Gennex Lab :

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Gennex Lab

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)


Gennex Laboratories Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Gennex Lab on 09-Jun-2023 17:11 is : 7.01.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 09-Jun-2023 17:11 the market cap of Gennex Lab stood at ₹ 123.0.
The latest PE ratio of Gennex Lab as of 09-Jun-2023 17:11 is 31.07.
The latest PB ratio of Gennex Lab as of 09-Jun-2023 17:11 is 2.36
The 52-week high of Gennex Lab is ₹ 9.10 and the 52-week low is ₹ 4.81.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue / sales of Gennex Lab is ₹ 67.12 ( Cr.) .

About Gennex Laboratories Ltd

Gennex Laboratories (formerly Prudential Pharmaceuticals) is a public limited company established in the year 1995 and has been engaged in the manufacturing of bulk drugs and intermediates. The company started as one of the leading manufacturer and exporter of bulk drugs and intermediates. Quality is the strength of the company and major part of its finished products are exported to various countries viz. Germany, United Kingdom, Spain, Singapore, Canada, Switzerland, Iran, Bangladesh, Pakistan and other major countries. Gennex Laboratories has diversified its activities to biotech products in order to have better prospects and opportunities for the company for expanding its bussiness activities and to meet the marketing requirements.

The company had commenced its commercial operations of Guaifenesin in November, 1995 and in a span of about one and half years, it was able to capture about 70% of the domestic market mainly due to the impeccable quality, aggressive marketing strategies, cost effective manufacturing and efficient distribution cum market penetration. It has also established itself fairly well in the export market and recognized well by many end-users and trading giants of international market.

The company has catered to countries like USA, Mexico, Spain and Germany and the quality has been accepted and appreciated extremely well with all the customers. Several customers have evinced interest on long-term tie-ups. Slowly but surely, the company is constantly expanding its reach to USA and European markets and it has been receiving very encouraging enquiries from prospective customers based on quality recommendations by existing customers. The company’s headquarters is situated in the heart of the city and the factory is situated at Survey No 133, IDA Bollaram, Jinnaram Mandal, Medak District-502 325, Andhra Pradesh, India. The factory occupies a total land area of 8,000 square meters. The total building floor space is1,945 square meters. The storage space is 500 square meters. The central lab has a floor space of 225 square meters.

Products of the company:

  • Guaiphenesin
  • Methocarbamol
  • Fluconazole
  • Phenazopyridine


  • Gennex Laboratories is an ISO 9001: 2008 approved company and obtained GMP Certification from the Central Drug Authority.
  • The company is also planning for ISO 14001: 2002 certification and OHSHAS 18000 to ensure its products are more widely accepted in the international market.
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now